To obtain the services of a quality assurance specialist III for cder, OPQ, OTR. The quality assurance specialist III will act as a lead quality management specialist. The contractor shall oversee the…
Ended Awarded Last action
- Contract number
- 75F40120F19107
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $167,166
Award facts
- Contract value 100% obligated
- $167,166.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- St. Louis, MO 63110, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$7,656 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $174,822 |
About this award
The Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a Blanket Purchase Agreement (BPA) call to Brillient Corporation, a Minority Owned Business, to obtain the services of a Quality Assurance Specialist III to act as a lead quality management specialist. The contract, valued at $167,166.20, has a period of performance through July 6, 2021 and was issued under the Professional Services Schedule (PSS) contract vehicle. Brillient, as the prime contractor, will oversee the quality management system including the administration of the Quality Assurance Specialist III role for the Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), and Office of Testing and Research (OTR).
Description
To obtain the services of a quality assurance specialist III for cder, OPQ, OTR. The quality assurance specialist III will act as a lead quality management specialist. The contractor shall oversee the quality management system including the adminis
Quick answers
Who was awarded contract 75F40120F19107?
75F40120F19107 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 7, 2020.
How much is contract 75F40120F19107 worth?
The government has obligated $167,166 on 75F40120F19107.
Is contract 75F40120F19107 an order under another contract?
Yes. 75F40120F19107 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40120F19107 competed?
The extent of competition for 75F40120F19107 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award